These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

555 related articles for article (PubMed ID: 26028656)

  • 41. Comparative outcomes of transvenous extraction of sprint fidelis and riata defibrillator leads: a single center experience.
    Richardson TD; Kolek MJ; Goyal SK; Shoemaker MB; Lewis AA; Rottman JN; Whalen SP; Ellis CR
    J Cardiovasc Electrophysiol; 2014 Jan; 25(1):36-42. PubMed ID: 24028661
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Factors predicting Sprint Fidelis lead fracture: Results at 5 years from a French multicentre registry.
    Piot O; Deballon R; Nitu D; Marquié C; da Costa A; Leclercq C; Defaye P; Sadoul N
    Arch Cardiovasc Dis; 2015 Apr; 108(4):220-6. PubMed ID: 25858538
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Generator exchange is associated with an increased rate of Sprint Fidelis lead failure.
    Lovelock JD; Patel A; Mengistu A; Hoskins M; El-Chami M; Lloyd MS; Leon A; DeLurgio D; Langberg JJ
    Heart Rhythm; 2012 Oct; 9(10):1615-8. PubMed ID: 22683747
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Risk factors for implantable defibrillator lead fracture in a recalled and a nonrecalled lead.
    Morrison TB; Rea RF; Hodge DO; Crusan D; Koestler C; Asirvatham SJ; Bradley D; Shen WK; Munger TM; Hammill SC; Friedman PA
    J Cardiovasc Electrophysiol; 2010 Jun; 21(6):671-7. PubMed ID: 20082653
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Transvenous implantable cardioverter-defibrillator lead reliability: implications for postmarket surveillance.
    Kramer DB; Hatfield LA; McGriff D; Ellis CR; Gura MT; Samuel M; Retel LK; Hauser RG
    J Am Heart Assoc; 2015 May; 4(6):e001672. PubMed ID: 26025935
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Predictive factors of lead failure in patients implanted with cardiac devices.
    Aizawa Y; Negishi M; Kashimura S; Nakajima K; Kunitomi A; Katsumata Y; Nishiyama T; Kimura T; Nishiyama N; Fukumoto K; Tanimoto Y; Kohsaka S; Takatsuki S; Fukuda K
    Int J Cardiol; 2015 Nov; 199():277-81. PubMed ID: 26218183
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Management of recalled implantable cardioverter-defibrillator leads at generator replacement: a decision analysis model for Fidelis leads.
    Burri H; Combescure C
    Europace; 2014 Aug; 16(8):1210-7. PubMed ID: 24469434
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Management of malfunctioning and recalled pacemaker and defibrillator leads: results of the European Heart Rhythm Association survey.
    Grazia Bongiorni M; Dagres N; Estner H; Pison L; Todd D; Blomstrom-Lundqvist C;
    Europace; 2014 Nov; 16(11):1674-8. PubMed ID: 25344962
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Clinical outcome of implantable cardioverter defibrillators with recalled and non-recalled leads in Japanese patients. Increased failure rate of the Sprint Fidelis lead.
    Yanagisawa S; Inden Y; Shimano M; Yoshida N; Ichiyanagi H; Fujita M; Ohguchi S; Ishikawa S; Kato H; Okumura S; Miyoshi A; Nagao T; Yamamoto T; Hirai M; Murohara T
    Circ J; 2014; 78(2):353-9. PubMed ID: 24270680
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Comparative study of the failure rates among 3 implantable defibrillator leads.
    van Malderen SC; Szili-Torok T; Yap SC; Hoeks SE; Zijlstra F; Theuns DA
    Heart Rhythm; 2016 Dec; 13(12):2299-2305. PubMed ID: 27496586
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Early failure of a small-diameter high-voltage implantable cardioverter-defibrillator lead.
    Hauser RG; Kallinen LM; Almquist AK; Gornick CC; Katsiyiannis WT
    Heart Rhythm; 2007 Jul; 4(7):892-6. PubMed ID: 17599673
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Significant differences in the expected versus observed longevity of implantable cardioverter defibrillators (ICDs).
    Shafat T; Baumfeld Y; Novack V; Konstantino Y; Amit G
    Clin Res Cardiol; 2013 Jan; 102(1):43-9. PubMed ID: 22798033
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Sudden and Fatal Malfunction of a Durata Defibrillator Lead due to External Insulation Failure.
    Shah AD; Hirsh DS; Langberg JJ
    Pacing Clin Electrophysiol; 2016 Jan; 39(1):101-4. PubMed ID: 26293817
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Passive-fixation lead failure rates and long-term patient mortality in subjects implanted with Sprint Fidelis electrodes.
    Vollmann D; Woronowicz S; Kmiec L; Jung K; Zenker D; Seegers J; Sossalla S; Dorenkamp M; Sohns C; Lüthje L; Hasenfuss G; Zabel M
    Europace; 2014 Feb; 16(2):258-64. PubMed ID: 23813451
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Multicenter experience with extraction of the Riata/Riata ST ICD lead.
    Maytin M; Wilkoff BL; Brunner M; Cronin E; Love CJ; Grazia Bongiorni M; Segreti L; Carrillo RG; Garisto JD; Kutalek S; Subzposh F; Fischer A; Coffey JO; Gangireddy SR; Saba S; Mittal S; Arshad A; O'Keefe RM; Henrikson CA; Belott P; John RM; Epstein LM
    Heart Rhythm; 2014 Sep; 11(9):1613-8. PubMed ID: 24854215
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Performance of the Durata implantable cardioverter defibrillator lead: results of an independent multicenter study.
    Rordorf R; Taravelli E; Forleo GB; Giannola G; Calzolari V; Tadeo G; Rossi S; Vicentini A; Curnis A; Serra P; Santamaria M; Calò L
    J Cardiovasc Med (Hagerstown); 2019 Oct; 20(10):676-681. PubMed ID: 31343450
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Cost of a recall of a single-center experience managing the Riata defibrillator lead.
    Hussain S; Moorman L; Moorman JR; DiMarco JP; Malhotra R; Darby A; Bilchick K; Mangrum JM; Ferguson JD; Mason PK
    Am J Cardiol; 2015 Jan; 115(2):206-8. PubMed ID: 25479754
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Prevalence of externalized conductors in Riata and Riata ST silicone leads: results from the prospective, multicenter Riata Lead Evaluation Study.
    Hayes D; Freedman R; Curtis AB; Niebauer M; Neal Kay G; Dinerman J; Beau S
    Heart Rhythm; 2013 Dec; 10(12):1778-82. PubMed ID: 23994078
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Comparative study about the tensile strength and yielding mechanism of pacing lead among major manufacturers.
    Chan CW; Chan LK; Lam T; Tsang KK; Chan KW
    Pacing Clin Electrophysiol; 2018 Jul; 41(7):828-833. PubMed ID: 29758585
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Complications of permanent cardiac pacing in patients with persistent left superior vena cava.
    Polewczyk A; Kutarski A; Czekajska-Chehab E; Adamczyk P; Boczar K; Polewczyk M; Janion M
    Cardiol J; 2014; 21(2):128-37. PubMed ID: 24526508
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 28.